Toward a comprehensive drug ontology: Extraction of drug-indication relations from diverse information sources

Journal of Biomedical Semantics

Volumn 8, Issue 1, 2017, Pages

  Sharp, Mark E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Drug indications; Drug information integration; Drug ontologies; Drug disease relations; UMLS; WHO ATC

Indexed keywords

BIOLOGICAL ONTOLOGY; DRUG DATABASE; NOMENCLATURE;

BIOLOGICAL ONTOLOGIES; DATABASES, PHARMACEUTICAL; TERMINOLOGY AS TOPIC;

EID: 85008465244     PISSN: None     EISSN: 20411480     Source Type: Journal    
DOI: 10.1186/s13326-016-0110-0     Document Type: Article

References (46)

1. Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, Goldberg LJ, Eilbeck K, Ireland A, Mungall CJ, Consortium OBI, Leontis N, Rocca-Serra P, Ruttenberg A, Sansone SA, Scheuermann RH, Shah N, Whetzel PL, Lewis S. The OBO foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol. 2007;25:1251-5.
2. Rubin DL, Shah NH, Noy NF. Biomedical ontologies: a functional perspective. Brief Bioinform. 2008;9:75-90.
3. Hoehndorf R, Dumontier M, Gkoutos GV. Evaluation of research in biomedical ontologies. Brief Bioinform. 2013;14:696-712.
4. Khanna I. Drug discovery in pharmaceutical industry: productivity challenges and trends. Drug Discov Today. 2012;17:1088-102.
5. The Gene Ontology Consortium. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43:D1049-56.
6. Meyer HF. Streamlining the research and development pipeline by coupling of information technology and biology. Drug Inf J. 2002;36:169-78.
7. Gardner SP. Ontologies and semantic data integration. Drug Discov Today. 2005;10:1001-7.
8. Bawden D, Robinson L. Pharmaceutical information: a thirty year perspective on the literature. Annu Rev Inf Sci Technol. 2010;45:63-119.
9. Hanna J, Joseph E, Brochhausen M, Hogan WR. Building a drug ontology based on RxNorm and other sources. J Biomed Semantics. 2013;4:44.
10. Tao C, He Y, Arabandi S. A 2013 workshop: vaccine and drug ontology studies (VDOS 2013). J Biomed Semantics. 2014;5:16.
11. Quan D. Improving life sciences information retrieval using semantic web technology. Brief Bioinform. 2007;8:172-82.
12. Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. Drug-target network. Nat Biotechnol. 2007;25:1119-26.
13. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P. Drug target identification using side-effect similarity. Science. 2008;321:263-6.
14. Boguski MS, Mandl KD, Sukhatme VP. Repurposing with a difference. Science. 2009;324:1394-5.
15. Hug H, Dannecker R, Schindler R, Bagatto D, Stephan A, Wess RA, Gut J. Ontology-based knowledge management of troglitazone-induced hepatotoxicity. Drug Discov Today. 2004;9:948-54.
16. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf. 2005;28:851-70.
17. Mendrick DL. Translational medicine: the discovery of bridging biomarkers using pharmacogenomics. Pharmacogenomics. 2006;7:943-7.
18. Iyengar R, Altman RB, Troyanska O, FitzGerald GA. Personalization in practice. Science. 2015;350:282-3.
19. Sharp M, Bodenreider O, Wacholder N. A framework for characterizing drug information sources. Proc AMIA Annu Fall Symp. 2008;6:662-6.
20. Sharp ME. Dimensions of drug information. PhD thesis. New Brunswick: Rutgers University, School of Communication and Information; 2011.
21. GenBank Home. http://www.ncbi.nlm.nih.gov/genbank/.
22. DrugBank. http://www.drugbank.ca/.
23. The PubChem Project. http://pubchem.ncbi.nlm.nih.gov/.
24. ChemIDplus Advanced. http://chem.sis.nlm.nih.gov/chemidplus/.
25. DailyMed. http://dailymed.nlm.nih.gov/.
26. WHOCC - ATC/DDD Index. http://www.whocc.no/atc_ddd_index/.
27. Medical Subject Headings. https://www.nlm.nih.gov/mesh/.
28. PubMed. http://www.ncbi.nlm.nih.gov/pubmed.
29. National Drug File Reference Terminology. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/NDFRT/.
30. UMLS. https://www.nlm.nih.gov/research/umls/.
31. Physicians' Desk Reference. https://en.wikipedia.org/wiki/Physicians'_Desk_Reference.
32. ChEBI The database and ontology of Chemical Entities of Biological Interest. http://www.ebi.ac.uk/chebi/.
33. Davis AP, Murphy CG, Johnson R, Lay JM, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, Rosenstein MC, Wiegers TC, Mattingly CJ. The comparative toxicogenomics database: update 2013. Nucleic Acids Res. 2013;41:D1104-14.
34. Comparative Toxicogenomics Database. http://ctdbase.org/.
35. About Us | USAN Council. https://www.ama-assn.org/about-us/usan-council ?
36. USP Dictionary. http://www.usp.org/store/products-services/usp-dictionary.
37. Adopted Names. https://www.ama-assn.org/about-us/adopted-names.
38. WHO-ATC-DDD (Defined Daily Dose) Index, 2005 release; Updates available at https://www.whocc.no/atc_ddd_index_and_guidelines/order/.
39. WHO Drug Dictionary, Sept. 1, 2013 release; Updates available at http://www.umc-products.com/DynPage.aspx?id=73588&mn1=1107&mn2=1139.
40. ChemIDplus, Substance Name: Aftobetin Hydrochloride [USAN]. http://chem.sis.nlm.nih.gov/chemidplus/name/contains/aftobetin%20hydrochloride.
41. MetaMap - A Tool for Recognizing UMLS Concepts in Text. https://metamap.nlm.nih.gov/.
42. UMLS Terminology Services - Metathesaurus Browser. https://uts.nlm.nih.gov//metathesaurus.html. [requires UTS login].
43. Library of Congress, Thesauri and Controlled Vocabularies. http://www.loc.gov/library/libarch-thesauri.html.
44. Zipf GK. The Psychobiology of Language. Houghton-Mifflin, 1935.
45. Li Q, et al. Mining FDA drug labels for medical conditions. BMC Med Inform Decis Mak. 2013;13:53.
46. Boyce R, Harkema H, Conway M. Leveraging the semantic web and natural language processing to enhance drug-mechanism knowledge in drug product labels. In: Proceedings of the first ACM international health informatics symposium: november 11-12, 2010. Arlington, VA, USA. 2010. p. 492-6.